Medtrum announced today that it made further progress toward bringing its 300-unit tubeless insulin patch pump to the German ...

PARSIPPANY, N.J., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, today announced it has ...

One of the diabetes market’s newest spinoffs is set to undergo a significant change. Embecta, which was spun out of Becton Dickinson in April of 2022, is instituting a restructuring plan that includes ...

Medtrum, a global diabetes technology company, today announced further progress toward the German launch of its 300-unit (300U) tubeless patch pump, following its presentation at DDG 2026 in Berlin ...

First Patients Began Device Training and Insulin Delivery Today, Marking Transition to a Commercial Company Pivot is the First Insulin Pump Designed to Address the Large, Underserved Population of ...

Modular Medical Inc. MODD, on Tuesday, announced that the first patients have completed onboarding and training and are now ...

The MarketWatch News Department was not involved in the creation of this content. -- Companies will jointly develop niia(TM) signature, an all-in-one wearable insulin patch pump that provides ...

Diabeloop, a pioneer in therapeutic artificial intelligence for diabetes management, today announces that DBLG2 ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The FDA granted 510(k) clearance for a tubeless insulin ...

FDA 510(k) Clearance Achieved: Pivot™ pump now cleared for commercial sale in the U.S. - major de-risking event unlocking revenue path. First-in-Class Removable Tubeless Patch Pump: 3 mL detachable ...

Surveyed Injection Users Would Consider Pump Therapy - if Easier to Learn and Improved Outcomes Conducting Additional ...